Results 321 to 330 of about 124,719 (350)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh
exaly  

Combination therapy with β3‐adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity

International journal of urology, 2016
A. Furuta, Yasuyuki Suzuki, S. Kimura, Yusuke Koike, S. Egawa, N. Yoshimura   +5 more
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Muscarinic acetylcholine receptors: structure and function

Biochemical Society Transactions, 1991
Carol A. M. Curtis, Edward C. Hulme, Eleonora Kurtenbach   +2 more
openaire   +3 more sources

BIOCHEMICAL STUDIES ON MUSCARINIC ACETYLCHOLINE RECEPTORS

Journal of Neurochemistry, 1976
Nigel J. M. Birdsall, E. C. Hulme
openaire   +3 more sources

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Molecular Properties Of The Muscarinic Acetylcholine Receptor

Annual Review of Neuroscience, 1987
openaire   +3 more sources

Tumor board presentation of a woman with metastatic, hormone receptor‐positive, mismatch repair‐deficient endometrial cancer

Ca-A Cancer Journal for Clinicians, 2022
Gini F Fleming, Jennifer A Bennett
exaly